From Event: 17th International Photodynamic Association World Congress, 2019
For evaluating and optimization of photodynamic therapy (PDT) efficacy, there is a strong need for imaging modalities that can provide (bio)markers fast, frequently and non-invasively. By combining multiple techniques, optical imaging can simultaneously quantify several PDT-response biomarkers including blood flow, oxygenation and photosensitizer (PS) fluorescence concentration during PDT. Additionally, fluorescence imaging can provide high contrast for visualization for PDT planning and dose optimization. I will present monitoring and predicting the PDT response of oral cancer at both preclinical and clinical settings. The results indicate that real-time blood flow measurements can provide useful feedback for PDT optimization in preclinical models, and that multi-parameter analysis of blood flow, PS fluorescence concentration and oxygen saturation can predict the response of oral cancer patients at the operating room. In the final part of the talk, I will present a novel, dual-channel, dual-modal theranostic endoscope that allows imaging, therapeutic light delivery, and light-triggered release of doxorubicin (Dox) from liposomes to optimize chemophotoherapy, the combination of PDT and chemo. The feasibility of noninvasive, continuous monitoring and optimization based on quantitative Dox/PS concentration distributions will be presented in an ovarian cancer model.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Ulas Sunar, "Optical imaging guided photodynamic therapy monitoring and optimization (Conference Presentation)," Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110704N (Presented at 17th International Photodynamic Association World Congress: July 03, 2019; Published: 14 August 2019); https://doi.org/10.1117/12.2527344.6069257188001.